Why Is HIMS & HERS HEALTH I A (HIMS) Stock Moving Today?
By the Top Tier Newswire AI Desk · August 10, 2026 at 12:51 AM ET · reviewed against 2 wire stories
HIMS & HERS HEALTH I A (HIMS) is drawing unusual attention today. Our newswire has captured 2 stories on HIMS across 2 sources in the last 36 hours, with AI sentiment reading mixed (avg 57/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
HIMS stock is moving higher today after rising 6.5% to close at $31.59 on Friday. The stock has gained 23.8% over the past eight sessions as investors look ahead to the company’s second-quarter earnings report on August 10. Options traders are anticipating a potential 14.5% move in the stock following the earnings release.
What Happened
Hims & Hers Health is preparing to report its second-quarter financial results, which has drawn attention from market participants. The telehealth platform has seen a recent rebound in its stock price amid broader industry developments. The company recently launched an AI-driven care experience for its weight loss members, aiming to provide personalized guidance and real-time progress monitoring. This follows increased competition in the GLP-1 medication space, with Amazon Pharmacy and CVS Health both expanding their weight management programs to include GLP-1 therapies.
The stock’s recent rise comes after a period of volatility, with the price climbing from $25.00 to $30.94 in the last eight trading sessions. The company remains unprofitable with a trailing twelve-month net margin of -0.6% and an earnings per share of -0.06, but revenue has grown by 32.8% year to date.
What The Data Shows
HIMS stock has shown a strong upward trend in the short term, with a beta of 2.42 indicating it is more volatile than the broader market. Insider transactions in the last 90 days include one buy totaling $1.2 million and eight sells totaling $3.9 million. The CFO, Okupe Oluyemi, has sold shares on three separate occasions in the past month. The stock is currently trading within its 52-week range of $13.74 to $65.30.
What To Watch
Investors should focus on the company’s second-quarter earnings report scheduled for August 10. The report will provide insight into how Hims & Hers is performing in a competitive telehealth and GLP-1 market.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
HIMS · today's session (5-min) · +0.10% vs prior close · updated 3:16 PM ETAI sentiment, last 36h · averaged over 2 stories · 57/100 bullish
The headlines behind the move
Story flow · 2 stories on the wire, last 36h · hover or tap a dot for the headline
1d agoTipRanksBULLISH 56Earnings
Hims & Hers Q2 Earnings Preview: Options Traders Brace for a 14.5% Move in HIMS Stock
Telehealth platform Hims Hers Health ($HIMS) will announce its second-quarter results on August 10. HIMS stock rose 6.5% to close at $31.59 on Friday. The opt...
1d agoBusiness InsiderBULLISH 57Earnings
Hims & Hers Q2 Earnings Preview: Options Traders Brace for a 14.5% Move in HIMS Stock
Telehealth platform Hims Hers Health (HIMS) will announce its second-quarter results on August 10. HIMS stock rose 6.
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →